Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

The Shadow of a Disease

September 16, 2014 9:37 am | by Max Planck Gesellschaft | News | Comments

In the future, some diseases might be diagnosed earlier and treated more effectively. Researchers at the Max Planck Institute for the Science of Light in Erlangen have developed an optical method that makes individual proteins', such as the proteins...

TOPICS:

Blood Test Could Help Determine Treatment Options for Esophageal Cancer Patients

September 16, 2014 9:30 am | by American Society for Radiation Oncology | News | Comments

A blood test may be beneficial in indicating neoadjuvant treatment regimens for patients with esophageal squamous cell carcinoma (ESCC), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th...

TOPICS:

Researchers Develop Improved Means of Detecting Mismatched DNA

September 16, 2014 9:20 am | by Johns Hopkins Medicine | News | Comments

Researchers at Johns Hopkins have identified a highly sensitive means of analyzing very tiny amounts of DNA. The discovery, they say, could increase the ability of forensic scientists to match genetic material in some criminal investigations...

TOPICS:
Advertisement

New York State a Beacon for Bio/Med Growth

September 16, 2014 9:13 am | by Jamie Leszczynski | News | Comments

The Bio/Med Breakthroughs: Advancing New York’s Innovation Economy industry report by MedTech, the trade association for bioscience and medical technology (Bio/Med) companies in New York, which was launched today at MEDTECH 2014, reveals a...

TOPICS:

Flowonix Submits PMA Supplements for Prometra Implantable Pump System

September 16, 2014 8:58 am | by Flowonix | News | Comments

Flowonix Medical Inc., a medical device company focused on providing advanced, implantable drug delivery solutions, today announced that it has submitted Premarket Approval (PMA) supplements to the U.S. Food and Drug Administration (FDA)...

TOPICS:

Polymer Tubing: The Hidden Hero Behind Innovative Neurovascular Procedures

September 16, 2014 8:30 am | by Emily Barnes, Market Specialist, Zeus, Inc. | Zeus | Articles | Comments

For nearly 50 years, Zeus polymer technology has been a precursor and enabler for the advancement of innovative therapies and lifesaving technologies within the neurovascular field. Our history as a critical supplier of delivery device components...

TOPICS:

The Productization Plan

September 16, 2014 8:30 am | by Dana Demeo, Chief Technical Officer, Intelligent Product Solutions | Intelligent Product Solutions | Blogs | Comments

Successfully bringing an idea from concept to completion requires coordination, planning, and vision even before you get to square one; we call this the Productization Plan. More often than not, if you were to look back at ideas that seemed...

TOPICS:

Stock Shapes for Industrial Applications

September 16, 2014 8:30 am | by MDT Staff | Ensinger | Product Releases | Comments

Ensinger’s DELRIN stock shapes are manufactured from DuPont DELRIN resin. They possess high tensile strength, creep and fatigue resistance, and excellent toughness. Engineers consistently specify DuPont DELRIN stock shapes made by...

Advertisement

Open Frame Power Supply Up to 150 Watts

September 16, 2014 8:30 am | by MDT Staff | CUI Inc | Product Releases | Comments

CUI Inc announced today that it has expanded its VOF series of compact, open frame ac-dc power supplies to include 100, 120, and 150W versions. The power supplies can accommodate a wide universal...

Predicting Prostate Cancer: Pitt-Developed Test Identifies New Methods for Treatment

September 15, 2014 2:08 pm | by University of Pittsburgh Schools of the Health Sciences | News | Comments

A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment. The analysis, published today in the American Journal of...

TOPICS:

What makes us get sick? Look upstream.

September 15, 2014 12:19 pm | by TED | Videos | Comments

Rishi Manchanda has worked as a doctor in South Central Los Angeles for a decade, where he’s come to realize: His job isn’t just about treating a patient’s symptoms, but about getting to the root cause of what is making them ill—the “upstream"...

TOPICS:

Blood-Cleansing Biospleen Device Developed for Sepsis Therapy

September 15, 2014 12:12 pm | by Wyss Institute for Biologically Inspired Engineering at Harvard | News | Comments

Things can go downhill fast when a patient has sepsis, a life-threatening condition in which bacteria or fungi multiply in a patient's blood – often too fast for antibiotics to help. A new device inspired by the human spleen and developed by...

TOPICS:

Genetic Testing Can Identify Men at Six-Fold Increased Risk of Prostate Cancer

September 15, 2014 11:58 am | by Institute of Cancer Research | News | Comments

Scientists can now explain a third of the inherited risk of prostate cancer, after a major international study identified 23 new genetic variants associated with increased risk of the disease. The study brings the total number of common genetic...

TOPICS:

Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 15, 2014 10:49 am | by PR Newswire | News | Comments

Abbott announced today positive one-year clinical results from ABSORB II, the world's first prospective, randomized, controlled trial comparing the safety and effectiveness of the dissolving Absorb heart device to Abbott's market-leading metallic...

TOPICS:

Congress Tackles LDT Regulation: FDA Authority and Adverse Events

September 15, 2014 10:27 am | by Richard Park, Contributing Editor | Blogs | Comments

Last week, the House of Representatives Energy and Commerce Committee’s Subcommittee on Health held a hearing on FDA’s notification to Congress at the end of July that it intends to issue draft guidance on a framework for oversight of laboratory...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading